Sidra Medicine Expands ENT Services QF Entity performs first pediatric vocal cord injection medialization procedure   06 February 2024, Doha, Qatar –Sidra Medicine, a member of Qatar Foundation, has expanded its pediatric Oto… Continue Reading.....

Sidra Medicine Pioneers New Pediatric Treatment Protocol for Infant with Congenital Hyperinsulinism 28 January 2024, Doha, Qatar – In a world first, Sidra Medicine, a member of Qatar Foundation, has pioneered a new treatment protocol for a young infant with congenital hyperinsulinism. The findings h… Continue Reading.....

Sidra Medicine Study Reveals Impact of Highly Processed Foods on Brain Metabolism and Sense of Smell 24 January 2024, Doha, Qatar – Researchers at Sidra Medicine, a member of Qatar Foundation, in collaboration with teams from the Universidade Federal do Rio Grande do Sul (Brazil) and Monell Chemical … Continue Reading.....

Sidra Medicine Study Recognized as Key Advancement in Cancer Microbiome Field 21 January 2024, Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, is proud to announce that one of its research studies published in Nature Medicine in May 2023, has been featured in the Ye… Continue Reading.....

Sidra Medicine and Hamad Medical Corporation to Co-host QPEM 2024 08 January 2024, Doha, Qatar – Sidra Medicine and Hamad Medical Corporation will co-host the 8th Qatar Pediatric Emergency Conference (QPEM) from 19 to 21 January 2024. QPEM 2024 aims is to provide hi… Continue Reading.....

Sidra Medicine and Nazarbayev University Sign Memorandum of Understanding 11 December, 2023, Doha, Qatar – Sidra Medicine (a member of Qatar Foundation) and Nazarbayev University in Kazakhstan, have signed a Memorandum of Understanding (MoU) to establish and develop levels … Continue Reading.....